{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:47:32Z","timestamp":1785235652693,"version":"3.55.0"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Activated phosphoinositide 3-kinase delta syndrome (APDS) is a primary immunodeficiency caused by gain-of-function mutations in the PIK3CD gene, leading to dysregulated immune responses. Clinical manifestations include recurrent infections, lymphoproliferation, and increased risk of malignancies. Due to its rarity and variable presentation, APDS is often misdiagnosed or diagnosed late.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We report a case of a 12-year-old girl presenting with persistent cervical lymphadenopathy. Imaging studies revealed extensive lymph node involvement and splenomegaly. PET-CT raised suspicion for lymphoma. Histopathology of the excised lymph node demonstrated Epstein-Barr virus (EBV) latent infection Type III, while whole exome sequencing identified a pathogenic PIK3CD c.3061G&amp;gt;A (p.Glu1021Lys) heterozygous variant. This confirmed the diagnosis of APDS. Targeted therapy with sirolimus was initiated, leading to significant regression of lymphadenopathy and splenomegaly. The patient maintained good clinical status during follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case highlights the importance of genetic testing in pediatric patients with lymphoproliferative disease and unusual infection patterns. Early diagnosis of APDS enables personalized, targeted treatment and avoids overtreatment with cytotoxic agents.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1622764","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:44:58Z","timestamp":1757655898000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Activated PI3K-\u03b4 syndrome presenting with cervical lymphadenopathy in a pediatric patient: a case report and review of the literature"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhiwei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jaci.2021.04.036","article-title":"International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome","volume":"149","author":"Dimitrova","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-019-08738-9","article-title":"Clinical, immunological, and genetic features in patients with activated PI3K\u03b4 Syndrome (APDS): a systematic review","volume":"59","author":"Jamee","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280840","article-title":"Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nationwide cohort: implications for clinical and epidemiological studies","volume":"108","author":"Boot","year":"2023","journal-title":"Hematologica"},{"key":"B4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5045\/br.2013.48.2.99","article-title":"Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma","volume":"48","author":"Lee","year":"2013","journal-title":"Blood Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1097\/MPG.0000000000002552","article-title":"Gastrointestinal mucosal lymphoid hyperplasia: mutation in PIK3CD gene","volume":"71","author":"Ezaizi","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/biom10010028","article-title":"Inhibition of growth of TSC2-null cells by a PI3K\/mTOR inhibitor but not by a selective MNK1\/2 inhibitor","volume":"10","author":"Evans","year":"2019","journal-title":"Biomolecules"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27165295","article-title":"Overview of Research into mTOR Inhibitors","volume":"27","author":"Mao","year":"2022","journal-title":"Molecules"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2323","article-title":"Secondary immunodeficiency in lymphoproliferative Malignancies","volume":"34","author":"Friman","year":"2016","journal-title":"Hematol Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1279652","article-title":"Future directions in the diagnosis and treatment of APDS and IEI: a survey of german IEI centers","volume":"14","author":"Vanselow","year":"2023","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2021.04.010","article-title":"Infections in activated PI3K delta syndrome (APDS)","volume":"72","author":"Brodsky","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106860","article-title":"Management of cytomegalovirus infection in allogeneic hematopoietic stem cell transplants","volume":"62","author":"Allaw","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031848","article-title":"Targeting PI3K\/AKT\/mTOR and MAPK signaling pathways in gastric cancer","volume":"25","author":"Morgos","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for hematological Malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Hematol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00338","article-title":"Respiratory manifestations of the activated phosphoinositide 3-kinase delta syndrome","volume":"9","author":"Condliffe","year":"2018","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.790455","article-title":"Autoimmune cytopenias and dysregulated immunophenotype act as warning signs of inborn errors of immunity: results from a prospective study","volume":"12","author":"Schiavo","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1622764\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:44:59Z","timestamp":1757655899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1622764\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":15,"alternative-id":["10.3389\/fimmu.2025.1622764"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1622764","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"article-number":"1622764"}}